The Patent Finder

Trillium Therapeutics Inc.

Also on record
Records under this name other than the patents Trillium Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Trillium Therapeutics Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,354,109Multimeric Fc receptor polypeptides
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,969,789Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,906,954Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,446,315Enhancement of CD47 Blockade Therapy by Proteasome Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,779,631Improvements in CD47 Blockade Therapy by Hdac Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,771,764CD47 Blockade with Radiation Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,178,803CD47 Blockade with Parp Inhibition for Disease Treatment
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,729,247Multimeric Fc receptor polypeptides
Formerly held
Lapsed on the fee record
Ended May 20, 2026 · USPTO record
Lapsed on the fee recordEnded May 20, 2026USPTO record
US 10,696,670Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
Lapsed on the fee record
Ended Jun 30, 2024 · USPTO record
Lapsed on the fee recordEnded Jun 30, 2024USPTO record
US 7,632,495Use of soluble fgl2 as an immunosuppressant
Formerly held
Term ended
Term ended Apr 15, 2024 · USPTO record
Term endedTerm ended Apr 15, 2024USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited